Director, President & CEO · Jazz Pharmaceuticals plc · Ordinary Shares
Side
SELL
Value
$473K
Shares
2,000
Price
$236.4
Executed
Oct 6, 2026
Disclosed
Oct 7, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 6 executedOct 7, 2026 disclosed
JAZZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gala Renee D filed this Form 4 reporting a open-market sale of JAZZ on Oct 6, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President & CEO
Gala Renee Dcik:0001607737
Issuer
Jazz Pharmaceuticals plccik:0001232524
Revision history · 0
No field has changed since this record was first ingested.
